Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China · Delayed Price · Currency is CNY 17.17
-0.81 (-4.51%)
May 28, 2026, 3:00 PM CST
SHA:605077 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 141.43 | 200.3 | 268.48 | 371.45 | 319.28 | 236.71 |
Depreciation & Amortization | 292.27 | 292.27 | 201.15 | 172.84 | 106.48 | 85.22 |
Other Amortization | 18.13 | 18.13 | 13.09 | 8.68 | 6.83 | 6.01 |
Loss (Gain) From Sale of Assets | -0.1 | -0.1 | 0.14 | 0.01 | -0.03 | -0.05 |
Asset Writedown & Restructuring Costs | 0.47 | 0.47 | 0.49 | 4.27 | 2.31 | 5.58 |
Loss (Gain) From Sale of Investments | -15 | -15 | -22.44 | -11.69 | -33.16 | -51.93 |
Provision & Write-off of Bad Debts | -5.64 | -5.64 | -2.08 | 0.17 | 6.89 | - |
Other Operating Activities | 184.65 | 121.69 | 22.36 | 21.77 | -1.35 | 6.45 |
Change in Accounts Receivable | -321.3 | -321.3 | -393.33 | 14.25 | -159.75 | -40.49 |
Change in Inventory | -90.02 | -90.02 | -410.94 | -20.14 | -161.1 | -75 |
Change in Accounts Payable | 234.47 | 234.47 | 451.3 | 51.5 | 161.12 | 86.9 |
Change in Other Net Operating Assets | 8.9 | 8.9 | 24.61 | 3 | - | 8.1 |
Operating Cash Flow | 428.5 | 424.4 | 146.5 | 619.47 | 271.98 | 264.32 |
Operating Cash Flow Growth | 62.97% | 189.70% | -76.35% | 127.77% | 2.90% | -21.15% |
Capital Expenditures | -557.06 | -483.38 | -1,430 | -690.7 | -539.75 | -360.93 |
Sale of Property, Plant & Equipment | 2.03 | 2.06 | 0.42 | 1.2 | 11.77 | 0.56 |
Cash Acquisitions | - | - | -53.02 | -528.88 | -21 | -47.17 |
Divestitures | - | - | - | - | - | 17.5 |
Investment in Securities | 41.64 | -90.61 | -132.45 | - | 47.27 | -890 |
Other Investing Activities | 20.53 | 22.95 | 28.64 | -40.18 | 565.63 | 25.09 |
Investing Cash Flow | -492.85 | -548.97 | -1,586 | -1,259 | 63.92 | -1,255 |
Long-Term Debt Issued | - | 1,487 | 682.41 | 2,328 | 696.7 | 156.07 |
Long-Term Debt Repaid | - | -672.31 | -798.78 | -490.23 | -192.88 | -182.89 |
Net Debt Issued (Repaid) | 382.27 | 814.69 | -116.37 | 1,838 | 503.82 | -26.82 |
Issuance of Common Stock | - | - | 7.72 | 77.37 | - | 1,394 |
Repurchase of Common Stock | -25.89 | -25.89 | - | - | - | - |
Common Dividends Paid | -255.5 | -253.47 | -196.56 | -173.09 | -111.94 | -120.34 |
Other Financing Activities | -473.51 | -478.01 | -5.34 | - | - | -26.9 |
Financing Cash Flow | -372.63 | 57.32 | -310.54 | 1,742 | 391.88 | 1,220 |
Foreign Exchange Rate Adjustments | 2.15 | 5.86 | 10.67 | 0.86 | 5.02 | -1.94 |
Net Cash Flow | -434.84 | -61.39 | -1,739 | 1,104 | 732.8 | 227.74 |
Free Cash Flow | -128.57 | -58.98 | -1,283 | -71.23 | -267.77 | -96.61 |
Free Cash Flow Margin | -2.82% | -1.41% | -45.69% | -2.56% | -12.17% | -6.06% |
Free Cash Flow Per Share | -0.42 | -0.19 | -3.39 | -0.24 | -0.90 | -0.34 |
Cash Interest Paid | 5.21 | 5.21 | 2.6 | - | - | - |
Cash Income Tax Paid | - | -42.29 | -132.84 | -45.42 | -95.23 | 3.57 |
Levered Free Cash Flow | -83.43 | 132.84 | -1,080 | -254.66 | -336.7 | -233.82 |
Unlevered Free Cash Flow | -20.05 | 196.21 | -1,059 | -231.45 | -327.8 | -231.38 |
Change in Working Capital | -188.68 | -188.68 | -353.32 | 47.46 | -135.89 | -23.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.